Heart Congress 2019 | Dubai | UAE | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

- Heart Congress 2019

Welcome Message

Heart Congress 2019 will provide an engaging and empowering educational environment that offers state-of-the-art updates, expert perspectives on challenging clinical decisions regarding patients with cardiovascular diseases, and tools to help clinicians navigate challenges faced in clinical practice with the collective goal of improving patient outcomes.

Heart Congress 2019 will especially focus our update on hypertension, prevention, heart failure, atrial fibrillation, valvular heart disease, and acute coronary syndromes.

We are delighted to invite you to Heart Congress Dubai, one of the leading conferences on congenital, structural and valvar percutaneous heart interventions, which will take place on Dec 02-03, 2019 in Dubai, UAE. This heart congress is gone for pediatric interventional cardiologists, cardiothoracic specialists, anaesthesiologists, researchers, professionals and some other therapeutic specialist to fame associated with congenital, structural or valvar interventions. We are assembling an energizing scientific program with addresses from leading experts and live case transmissions displaying skillful administrators from everywhere throughout the world.

Join us for the full two-day program at Heart Congress Dubai.

We look forward to welcoming you to Dubai in December!

Yours sincerely,

Heart Congress 201

About Conference

It’s a pleasure and honor to invite you to join us at the 10th World Heart congress, which is scheduled on December 02-03, 2019 at Dubai, UAE. The objective of this conference is to educate and aware people with recent advancements innovations and modernizations in the field of Cardiology, Cardiovascular Diseases, and heart diseases.

Cardiology Conference invites participants from universities, research institute, cardiology societies, and diagnostic companies to share your explorations and research experiences on all related aspects of cardiology, providing a showcase of the latest techniques and innovations. Learning should be pleasurable. This event is designed to enhance knowledge about Cardiology and Heart disorders in a warm and friendly environment.

Motives to Attend Cardiology Conference 2019

• Keynote presentation along with interactions to galvanize the scientific community.

• Workshop and Symposiums to reach the largest assemblage of participants from the Cardiology and Healthcare community.

• A wide track of exhibitors to showcase new and emerging technologies in cardiology arena Platform to the global investment community to connect with stakeholders in the Cardiology field.

• Young Scientist/ Investigators Award geared towards best budding young research.

• Links to the political marketing resources in order to expand your business and research network.

• Triumph of Awards, Certificates recognize your commitment to your profession to encourage nascent research.

Benefits of Attending Cardiology Conference 2019:

·Offers a great platform for experiencing and refreshing your knowledge base amid world-class scientists and researchers.

· The attendees will conquer the latest advances, innovations and networking with professionals across the globe.

· Act as career guidelines for young researches and motivates them by young researcher awards.

· Meet Eminent Experts and Influencers Face to Face.

· New Tactics and Tips to enhance your views.

· You can conduct a special session or workshop about your research.

· Abstract page and speaker page will be created in Google on your name.

Why attend?

Opportunity to meet incredibly famous speakers, researchers, specialists, Business giants, and the most up to date refreshes in Cardiology and Healthcare world are important for this the conference leads to the significance of this meeting.

This is the best stage to grow the new association and coordinated efforts.

For accelerating your course this is the best location in each domain in the whole World.

In our Conference, 89% of participants who are the Key contact in labs buying choices.

During this meeting, Our Exhibitors were visited 4-5 times by 80% of the participants.

By this meeting, the network can be created with both Academia and Business.

Why Dubai?

Dubai is a country in Asia with a global financial center and Multicultural Population. Cardiovascular Diseases are very common in Asia where it is a leading cause of death in many parts of Asia. Though North America is the largest market for cardiology, Asia Pacific is the fastest-growing region in the forecast period. Asian’s market for cardiovascular diseases is growing faster and it will continue to do so as many Asian governments implemented many national health care policies and reforms which addresses cardiovascular health.

Intended audiences:

Directors, Head of Department, Professors, Industrial Researchers, Cardiologists, Doctors, Cardiology Researchers, Surgeons and Students from academia in the research of Heart Diseases and Cardiology.

Academia: 65%

Industry: 25%

Others: 10%

A Unique Opportunity for Advertisers and Sponsors at this International event.

Exhibition/Sponsorship Opportunities Available @ heartcongress(at)alliedforums(dot)com

Scientific Sessions/Tracks

Session on: Cardiology

Cardiology is a branch of medicine dealing with disorders of the heart be it human or animal. The field incorporates medical analysis and treatment of innate heart defects, coronary vein malady, heart disappointment, valvular coronary illness andelectrophysiology. Doctors who represent considerable authority in this field of prescription are called cardiologists. Pediatric cardiologists are pediatricians who are specialized in cardiology.

Related Conferences: 4th AnnualAdvances pulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference, November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Cardiac Diseases

Cardiac disease is the disorder that influences your heart. Diseases under the coronary disease incorporate blood vessel diseases, for example, coronary artery disease; arrhythmias; and heart imperfections you're brought into the world with for example congenital heart defects, Hypertension, heart failure, Cardiomyopathy, Ischemic heart disease, etc. CardiacDisease is a general term for conditions influencing the heart or veins. It's normally connected with the development of fat deposits inside the arteries– known as atherosclerosis – and an expanded danger of blood clots.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Heart Failure

Heartfailure burden is on the constant increase in our country and overthe last few years this is being increasingly recognized as a subspecialty. Heart Congressapproaches for better medical management and interventions have proved toimprove the quality of life of these patients. Heart failure happenswhen the pumping activity of your heart isn't sufficiently able to move bloodaround, particularly under pressure. Moreover, the heart muscle may not unwindappropriately to oblige the progression of blood once again from the lungs tothe heart. These variations from the norm in cardiac function can make fluid toback up in your lungs and in different pieces of your body. At times the fluidin your lungs can accumulate to the point where it can cause a dangerouscondition called acute pulmonaryedema, requiring crisis treatment.

Session on: Atrial Fibrillation and Arrhythmias

Atrialfibrillation (AF), the most common sustained cardiacarrhythmia, is associated with increased rates of mortality. Inflammation has longbeen known to play a role in the pathogenesis of atrial fibrillation. Therapiesincluding anticoagulants, anti-arrhythmic medications, devices, andnon-pharmacologic procedures in the last 30 years have improved patients'functionality with the disease. It stays basic that further examination into atrial fibrillation thestudy of disease transmission, hereditary qualities, detection, and medicineskeeps on pushing forward quickly.

Session on: Congenital Heart Disease and Paediatric Cardiology

PaediatricCardiology is basically focused on clinical examinations, experimentalundertakings and assessment of new procedures with potential applications to paediatricresearch on people. The objective of this session is to quickeninterchanges in paediatriccardiology, to encourage the knowledge sharing and to invigorate theresearch in the field. Clinical papers emphasizing medical and surgical aspectsof all aspects of heart disease ininfants, children, and adolescents, including embryology and anatomy,physiology and pharmacology, biochemistry, pathology, genetics, radiology,clinical aspects, investigative cardiology, electrophysiology and echocardiography, and cardiacsurgery are welcomed.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Interventional Cardiology and Cardiovascular Surgery

The improvement of heartsurgery and cardiopulmonary sidestep procedures has lessened thedeath rates of these surgeries to generally low positions. For example, repairsof inborn heartdeformities are at present assessed to have 4-6% death rates.It is often used to treat complications of ischemicheart diseases like coronary artery bypass grafting, to correct congenitalheart disease; or to treat valvular heart disease from variouscauses, including endocarditis,rheumatic heart disease, and atherosclerosis. There will be expandeddiscussions regarding the new advanced technologies in cardiac surgery and transplantationprocesses. This session focuses to provide a platform for researchers,practitioners and educators to present and discuss the most recent innovations,trends, and concerns as well as practical challenges encountered, and solutionsadopted in the fields of Cardiology and Cardiac Surgery.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Diabetes and Heart Disease

Diabetes patients have anincreased risk of heartdisease. Moreover, cardiovascular complications are the leadingcauses of morbidity and mortality among patients with diabetes.Diabetes could legitimately influence themyocardial function and viability, even without atheroscleroticocclusive illness, henceforth leading to heart attack and diabetic cardiomyopathy. Currenttreatment of basic heart issues that are quickened by diabetes isn'tdistinctive to that of nondiabetic patients with cardiovascular pathologies. HeartCongress 2019 invite papers related to diabetes and cardiologywhich highlights all aspects of both diseases’ interaction:epidemiology, genetics, physiopathology, treatment, andprevention.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World HeartRhythm Conference, November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Thyroid Disease and the Heart

Thyroid gland issues can resultin the cardiac problems. One of the most important reasons to diagnose andtreat thyroid disease is to prevent the cardiac conditions that can result fromit. Thyroiddisease affects the heart either by producing too little thyroidhormone (a condition called hypothyroidism) or toomuch thyroid hormone (called hyperthyroidism). Bothtype of thyroid disorders can have a significant effect on the heart.Researchers shows two thyroid disorders – subclinical hypothyroidism and low T3syndrome – might make heartfailure worse.

Session on: Cardiac Imaging

Cardiovascularimaging is a basic advance in the exact determination of numerousheart conditions. Through these techniques, cardiologist canassess the size and structure of a patient's heart and perceive how well itfunctions. This session will pave way to develop ultrasound contrast agents andimaging systems with the goal of moving basic discoveries in ultrasound-based molecularimaging into clinical practice.

Session on: Cardiovascular Nursing and Healthcare

Cardiac nurses andallied experts are on the bleeding edge of the fight to decrease the weight of cardiovasculardisease and will examine better approaches to assess risk, prompt andtreat their patients.Cardiovascular nurses have been a significant supporter of improving cardiachealth since the commencement of the coronary care units. Cardiovascularnursing has advanced monstrously alongside improvements in innovationand the treatment and prevention of cardiac disease. Heartresearch and innovative work prompts fast clinical changes which require nursesand allied experts to be refreshed with the most recent information ontreatment and care. Future research on should be led on the role of cardiovascularnurse in patient instruction and risk factor management in theanticipation of CVD, just as in intense heart care. In this session, heartcongress 2019 invites the researchers to submit their works onthe topics but are not limited to Acute and Chronic HeartFailure; Improving Care in Hospital and Community; Coping withPatient and Family Issues at End of Life; Prevention and Support in Transplant,among others.

Session on: Women & Heart Disease

Cardiologydisease is the main killer of women in America. Every year a largernumber of women die of cardiologydisease than men, yet cardiology disease and related risk componentsare frequently missed in ladies. Indications of coronaryheart disease and heart failure, for instance, are frequentlydiffer in women than their male partners. Women are likewise less inclined toget ideal treatment for certain heart conditions. A women’s side effects arefrequently not quite the same as a man's, and she's substantially more likelythan a man to die within a time of showing at least a bit of heart attack.Research is just currently starting to reveal the biological, medicinal, andsocial bases of these and different contrasts. The expectation is that newlearning will prompt advances in fitting anticipation and treatment to ladies.

Session on: Digital Health and Cardiology

Digitalhealth is the use of digital information, data and communicationtechnologies to collect, share and analyse health information to improvepatient health and health care delivery. In spite of the fact that cardiology is onthe front line of therapeutic and methodology related advancements, the fieldis lacking in selection of digital tools in medicinal services delivery. Theseadvances could encourage and propel progressively regular randomized clinicaltrials (RCTs), which is especially essential since RCTs are ending upprogressively costly and complex, are moderate to finish and takes time toimplement into practice. Mobilehealth or mHealth, is the subset of digital health thatfocuses on the use of mobile and wearable devices and software applicationsThis session is tailored to give a platform to focus on current and potentialapplications of artificial intelligence in cardiovascularmedicine. This session at HeartCongress 2019 expects the researchers to submit their researchabstracts on topics but are not limited to AI inCardiology, early applications of AI in general and specific to healthcare,and a pioneering application of AI inCardiology, AI in medical informatics, imaging processing, and clinicaldecision making. This session is intended for cardiologists, critical carephysicians, clinical investigators, computer scientists, data scientists,engineers, and other medical and computer professionals who are interested in acontemporary review of machine learning and its applications to medicine andspecifically to cardiology.

Session on: Cardiovascular Pharmacology

CardiovascularPharmacology deals with the study of drug action which exertsa biochemical or physiological effect on the tissue, cell, organ or organism.The interactions affect normal or abnormal biochemical function. Thecardiovascular group is studying the connections between salt intake or obesityon blood pressure control mechanisms. These investigators use state of the artmolecular, cellular and integrative approaches to study the vascular functionand neural control of blood pressure. It elaborates safety data of detrimentaleffects of new cardiovascularmedicines. Pharmacology ofvascular endothelium deals with modifications of endothelial cells and thevasculature play a crucial part in the pathogenesis of a wide range of the mostdreadful of human diseases, as endothelial cells have the vital role ofparticipating in the maintenance of patent and functional capillaries.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Session on: Stem cell and Regenerative Biology

Regenerative medication and stemcells are regularly expressed inside a similar breath, in light ofcurrent circumstances. There is a basic need to recognize stem cells that canframe spontaneously beating cardiomyocytes (CMs) and empower regeneration.Utilization of Cdx2 cells may play a vital development, as these stem cells aremultipotent and immunologically naive, with a remarkable proteome, contrastedand embryonic stemcells. Additionally, they show the capacity to specifically home tosites of injury. These qualities prepare for novel allogeneic stem celltreatment for cardiovascular infection. Specialists have figured out how toutilize placental stemcells to recover heart cells in mice, which could prompt momentousnew medications for heartattack patients.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Market Analysis

According to a new report by Grand View Research, Inc, the global cardiology market size was valued at USD 116.9 billion in 2017 and is expected to grow at a CAGR of 7.4% over the determined forecast period 2017-2022. Increase in the generality of Congenital Heart Defects and the presence of technologically advanced cardiology and cardiovascular valves, grafts, and patches are among fundamental factors expected to drive development over the forecast period.

According to the WHO report in May 2018, the mortality rate of the population in Asia and the Middle East region is due to the increase in cardiology diseases. With new drugs and devices entering the market, there is rapid growth in the global cardiology therapeutics market. Diabetes is one of the major factors leading to the current cardiovascular disease epidemic according to our cardiology market research expert. The growing number of chronic diseases such as diabetes, heart attack is the major section leading to the growth of the cardiology failure market. The cardiology market size is expected to grow in the coming years due to the potential breakthrough of newly authorized drugs entering the market.

Some of the Scientific advancements are also expected to drive the cardiology devices market in the fields of material sciences, interventional cardiology, and cryopreservation. The utility of expanded Polytetrafluoroethylene for cardiovascular patches, the introduction of transcatheter heart valves, and the process of minimally invasive technologies, such as transcatheter aortic valve implantation or transcatheter aortic valve replacement is among the few elements expected to raise the growth over the predicted period. In addition, modification in cryopreservation methods by key performers such as CryoLife is among major technological advancements in cardiology and CTVS therapies that are expected to positively influence the market.

North America is the topmost contributor to the global cardiology market with 6.8% of CAGR which is followed by Europe, Asia Pacific, Latin America, and Middle East Asia.

UAE- Asia Pacific region market for Cardiology management devices, Aortic Repair devices, transcatheter embolization and occlusion devices will grow through 2026 and is driven by some factors such as aging population, sedentary lifestyle and change in food habits, advance findings in the field cardiology as well as the rise in the number of interventional cardiologists, and increasing demand for surgical techniques.

Scope and importance:

The goal of Cardiology and Cardiovascular diseases are to give a high-quality cure and treatment to the patients with a novel approach of the upcoming market such as cardiovascular medicines, devices, and diagnostics tool. Cardiology diseases establish an essential component of the surgical disease concern i.e., it has facilitated the cultivation of surgical skills, capacity, and mutual learning in low and middle-income countries. This continues to strengthen Cardiology growth through such a partnership, embracing safety, sustainability, and choice of care on behalf of our patients and their family unit.

Target Audience for this Report:

Cardiac Surgeons

Cardiologist

Epidemiologist

Interventional Cardiologist

Paediatric Cardiologist

Cardiology Researchers

Echo cardiologist

Invasive Cardiologist

Cardiac anaesthesiologist

Product Outlook (Revenue, USD Million, 2014 - 2025)

Cardiovascular devices

Electrocardiogram

Remote Cardiac Monitoring

Heart Valve Repair

Cardiovascular Grafts

Endovascular stent graft

Haemodialysis access graft

Peripheral vascular graft

Cardiovascular Patches

Material Outlook (Revenue, USD Million, 2014 - 2025)

Synthetic patches

Biological patches

Application Outlook (Revenue, USD Million, 2014 - 2025)

Cardiac repair patches

Atrial septal defect

Common atrium

Defects of the endocardial cushion

Ventricular septal defect

Tetralogy of Fallot

Suture bleeding

Vascular Repair Patches

Carotid endarterectomy

An anomalous connection of the pulmonary veins

Transportation of the great vessels

Reconstruction of the portal and superior mesenteric veins

Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

The Middle East and Africa

South Africa

Key Players:

Bard Peripheral Vascular

Medtronic

Terumo Cardiovascular Systems Corporation

W.L. Gore & Associates, Inc.,

Getinge AB

CryoLife, Inc.

Edwards Life sciences Corporation

Baxter and Amadeus.

Globally: Top-Ranked Hospitals for Heart Diseases & Cardiology

Cleveland Clinic, Ohio

Mayo Clinic, Rochester

New York-Presbyterian University Hospital of Columbia and Cornell, New York

St Francis Hospital, Roslyn, New York

Mount Sinai Hospital, New York

Duke University Hospital, Durham

Brigham and Women's Hospital, Boston

Massachusetts General Hospital, Boston

Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia

Cedars-Sinai Medical Center, Los Angeles

Worldwide: Associations and Societies

American Heart Association (AHA)

Heart Failure Society of America

American Association of Heart Failure Nurses (AAHFN)

Association for European Pediatric Cardiology

European Society of Cardiology

Heart Valve Society of America (HVSA)

International Society for Heart Research (ISHR)

Working Group for Cardiac Magnetic Resonance Spanish Society of Cardiology

Society of Invasive Cardiovascular Professionals

Industries Globally for Cardiology Research

Sanofi

AstraZeneca

GlaxoSmithKline

Care stream Health

Intelomed

Keystone Medical Technologies

Worldwide Universities

University of Oxford

Harvard University

Stanford University

Yale University

Duke University

Columbia University

Imperial College London

University of Sydney

University of Basel

New York University (NYU)

Organizing committee members

Franz H. Messerli

Professor, Cardiology

Icahn School of Medicine at Mount Sinai, USA

Professor François Mach

Head of Cardiology, Cardiology

Geneva University School of Medicine, Switzerland

William J Rowe

Former Assistant Clinical Professor of Medicine, Medicine

Medical University of Ohio at Toledo, USA

Renowned Speakers

Professor Uwe Klima

Managing and Medical Director, Cardiac - Thoracic and Vascular Surgeon

German Heart Centre, UAE

SOPHIE MAVROGENI

Vice-Director, Cardiology

Onassis Cardiac-Surgery Center, Greece

To Collaborate Scientific Professionals around the World

Conference Date	December 02-03, 2019
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Quick Links

Download Brochure

Submit Abstract

Contact Desk

General Enquiries Albero Kent [email protected] +44 20 3769 1755
Sponsors/Exhibiting/Advertising Albero Kent [email protected] +44 20 3769 1755

Conference Highlights

Session on: Cardiology Session on: Cardiac Diseases Session on: Heart Failure Session on: Atrial Fibrillation and Arrhythmias Session on: Congenital Heart Disease and Paediatric Cardiology Session on: Interventional Cardiology and Cardiovascular Surgery Session on: Diabetes and Heart Disease Session on: Thyroid Disease and the Heart Session on: Cardiac Imaging Session on: Cardiovascular Nursing and Healthcare Session on: Women & Heart Disease Session on: Digital Health and Cardiology Session on: Cardiovascular Pharmacology Session on: Stem cell and Regenerative Biology

Previous Conferences

Past Conference Report

Supporting Journals

Journal of Invasive and Non-Invasive Cardiology

Journal of Cardiovascular Medicine and Therapeutics

Tweets by Heart Congress 2019

Special Issues

All accepted abstracts will be published in respective Allied Academies Journals.

Abstracts will be provided with Digital Object Identifier by

Welcome Message

About Conference

Scientific Sessions/Tracks

Market Analysis

Organizing committee members

Renowned Speakers

To Collaborate Scientific Professionals around the World

Submit Abstract

Previous Conferences

Allied Academies Global Conference Directory

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Conferences by Subject

Medical & Clinical Conferences

Non Medical Conferences